|Podcasts|September 3, 2020
Episode 64: The Complexities of Managing ADHD
Author(s)Elaine Quilici
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
Advertisement
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
President Trump Imposes 100% Tariffs on Branded Pharmaceuticals
2
Pfizer and BioNTech Pause Covid Vaccine Study Following Low Enrollment Totals
3
FDA Approves Foundayo Under National Priority Voucher Program
4
The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation
5